Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine.
Engineering Protein Nanoparticles Functionalized with an Immunodominant Coxiella burnetii Antigen to Generate a Q Fever Vaccine.
复制标题
DOI:
10.1021/acs.bioconjchem.3c00317
复制
发表时间:
2023-09-20
影响因子:
4.7
通讯作者:
Wang, Szu-Wen
中科院分区:
文献类型:
--
作者:
Ramirez, Aaron;Felgner, Jiin;Jain, Aarti;Jan, Sharon;Albin, Tyler J.;Badten, Alexander J.;Gregory, Anthony E.;Nakajima, Rie;Jasinskas, Algimantas;Felgner, Philip L.;Burkhardt, Amanda M.;Davies, D. Huw;Wang, Szu-Wen
Coxiella burnetii is the causative agent of Q fever, for which there is yet to be an FDA-approved vaccine. This bacterial pathogen has both extra- and intracellular stages in its life cycle, and therefore both a cell-mediated (i.e., T lymphocyte) and humoral (i.e., antibody) immune response are necessary for effective eradication of this pathogen. However, most proposed vaccines elicit strong responses to only one mechanism of adaptive immunity, and some can either cause reactogenicity or lack sufficient immunogenicity. In this work, we aim to apply a nanoparticle-based platform toward producing both antibody and T cell immune responses against C. burnetii. We investigated three approaches for conjugation of the immunodominant outer membrane protein antigen (CBU1910) to the E2 nanoparticle to obtain a consistent antigen orientation: direct genetic fusion, high affinity tris-NTA-Ni conjugation to polyhistidine-tagged CBU1910, and the SpyTag/SpyCatcher (ST/SC) system. Overall, we found that the ST/SC approach yielded nanoparticles loaded with the highest number of antigens while maintaining stability, enabling formulations that could simultaneously co-deliver the protein antigen (CBU1910) and adjuvant (CpG1826) on one nanoparticle (CBU1910-CpG-E2). Using protein microarray analyses, we found that after immunization, antigen-bound nanoparticle formulations elicited significantly higher antigen-specific IgG responses than soluble CBU1910 alone and produced more balanced IgG1/IgG2c ratios. Although T cell recall assays from these protein antigen formulations did not show significant increases in antigen-specific IFN-γ production compared to soluble CBU1910 alone, nanoparticles conjugated with a CD4 peptide epitope from CBU1910 generated elevated T cell responses in mice to both the CBU1910 peptide epitope and whole CBU1910 protein. These investigations highlight the feasibility of conjugating antigens to nanoparticles for tuning and improving both humoral- and cell-mediated adaptive immunity against C. burnetii.
登录
查看更多内容
DOI:
10.4049/jimmunol.1002122
发表时间:
2011-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Duggan JM;You D;Cleaver JO;Larson DT;Garza RJ;Guzmán Pruneda FA;Tuvim MJ;Zhang J;Dickey BF;Evans SE
通讯作者:
Evans SE
影响因子:
9.2
作者:
Nguyen B;Tolia NH
通讯作者:
Tolia NH
影响因子:
3.7
作者:
Chen C;Dow C;Wang P;Sidney J;Read A;Harmsen A;Samuel JE;Peters B
通讯作者:
Peters B
影响因子:
17.1
作者:
Bruun TUJ;Andersson AC;Draper SJ;Howarth M
通讯作者:
Howarth M
影响因子:
8.2
作者:
Li, Enya;Brennan, Caroline K.;Ramirez, Aaron;Tucker, Jo A.;Butkovich, Nina;Meli, Vijaykumar S.;Ionkina, Anastasia A.;Nelson, Edward L.;Prescher, Jennifer A.;Wang, Szu-Wen
通讯作者:
Wang, Szu-Wen